# CITALOPRAM HYDROBROMIDE

NDC: 71610-092
Generic name: CITALOPRAM
Labeler / Manufacturer: Aphena Pharma Solutions - Tennessee, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20171110

FDA application: ANDA077534

## Active ingredients

- CITALOPRAM HYDROBROMIDE: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71610-092"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71610-092
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d05f4e71-95f3-4f22-8b01-b21e5c19e0f2